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In this study, we analyzed healthcare provision and health expenditure across six
Mediterranean countries that adopt the National Health System (Beveridge model) and
that form part of the European Union (EU) with the main aim being that of analyzing and
comparing out-of-pocket health spending in countries with a European Mediterranean
connection. To this end, we considered various economic indicators and statistics to
derive commonalities and differences across these countries and also compared trends
in these indicators to those observed across the rest of the EU. We then analyzed
these findings in light of other data related to the quality of healthcare delivery and the
infrastructure of the health system and discussed recent developments in healthcare
within each country and the main challenges faced by the respective health systems. The
results show that on average, Mediterranean countries spend less on total healthcare
expenditure (THE) than the EU average, both as a proportion of GDP, as well as in
per capita terms. This is primarily driven by lower-than-EU-average public funding of
healthcare. The 2008/2009 macro-economic and financial crisis had a significant impact
on the countries under review, and explains the persistent reductions in public health
spending as part of the austerity measures put in force across sectors. On the flipside,
Mediterranean countries have a higher presence of private health providers in total
funding, thereby explaining the higher Out-of-Pocket (OOPs) health expenditures in these
countries relative to the EU-average. With regard to the overall health infrastructure in
these countries, we observed that although the supply of physicians is largely in line
with the rest of the EU, there is under-supply when it comes to hospital beds. This may
be symptomatic of lower government funding. Nonetheless, all countries score highly in
the evaluation of the quality of health services, as recorded by international rankings
like the WHO’s 2000 metric, whereas health system performance indicators, namely
mortality rates and life expectancy reveal favorable health outcomes in the Mediterranean
EU countries. The findings in this paper may be seen in light of the Mediterranean
region’s lifestyle in terms of diet, health behavior, health beliefs and shared culture. In
particular, the higher out-of-pocket expenditure may reflect the tendency for one-to-one
relationships with private clinicians and the pursuit of person-centered care (1).
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Additionally, the Mediterranean people may not be as disciplined as their European
counterparts in accessing and using the public health sector. The lower THE also
reflects the fact that the Mediterranean countries are less wealthy than the more
economically-advanced European countries.
Keywords: European, Mediterranean connection, out-of-pocket health spending, National Health Systems,
Healthcare
INTRODUCTION
In most countries, the level of expenditure on healthcare is
increasing over time, largely due to their allotment of a higher
proportion of the national financial budget (2–4). In fact, various
factors have and are contributing to the growth in countries’
health care expenditure, which has outpaced inflation over the
past decades. This expenditure has more than doubled even
though the average world life expectancy has only increased by
3 years over the same period (1990–2008) (5). In the European
Union (EU), this trend is most striking since its development
is recorded as higher than in other countries. The actual
factors contributing to this observation are embedded in the
societal changes that have crept in over the years. These include
prosperity diseases and aging population (6, 7), which impact the
structures of healthcare and the budgets set to cover the health
needs of the countries’ citizens.
Various theoretical and empirical studies such as those
by Ogura and Jakovljevic (6) and Dieleman et al. (3), have
examined the linkages among different groups of countries’
health spending. The contribution of this paper is to specifically
focus on European countries with a Mediterranean connection,
especially in relation to out-of-pocket spending, that have
a similar health system model of, namely the (Beveridge)
National Health System (NHS), which is provided and financed
by the government through tax payments (8). Almost all
hospitals and clinics are owned by the government. Doctors
tend to be employed with the government, although some
work entirely privately and others work privately on top of
their government job (9). Specifically, the countries in this
study are Spain, Cyprus, Greece, Italy, Malta, and Portugal
(the latter also included due to its proximity with Spain),
which do not fall within any other group studied so far.
Purposefully, we have excluded France and Croatia in view
of their health system being modeled on the [Bismarck]
Social Security Health System. However, we decided to include
Portugal in view of its NHS model as well as its proximity to
Spain.
Across the Mediterranean countries (including Portugal),
health expenditure varies considerably and as in other parts
of the world, the demand on healthcare in this region is on
the rise. Since the 2008 macro-economic crisis, health spending
was markedly reduced across the EU after years of continuous
growth. The substantial variation in the distribution of health
expenditure across European and Mediterranean countries is
reflected in different types of expenditure, whether public, private
or insurance-based. The Mediterranean countries adopted a
number of measures to contain healthcare costs, namely changes
to public funding, the introduction of user charges, changes in
entitlements, the introduction of health technology assessment
and the restructuring of healthcare services [e.g., 10–12].
In our comparative research of these countries, we aim to
demonstrate the extent to which structure and finances vary or
are similar, especially in relation to out-of-pocket spending in the
health sector. We explore whether the countries in this region
offer similar health services and have similar influences in terms
of culture, traditions, climate and diet. In this manner, we will be
able to determine whether these influences play a major part in
the decisions related to health expenditure. Moreover, the paper
aims to uncover trends over time in these countries that may be
useful for developed, developing and underdeveloped countries
for future readiness and forecasts (13).
METHOD
The methodology of this research was based on a detailed
analysis and evaluation of a series of data indicators related
to health expenditure patterns in each country. Indicators
related to health expenditure reflect performance of health
systems, albeit the extent to which health expenditure could
influence health system efficiency is still debatable (8). We
have also utilized formal government releases, policy documents
and literature in peer-reviewed journals as required for this
research in order to provide context to the data. Quantitative
data used in this paper were drawn from the WHO’s Global
Health Expenditure Database (14), to ensure both reliability
and consistency. We used world standards such as total health
expenditure (THE) (aggregated, private and public) in US$,
the value of Out-of-Pocket (OOPS) health expenditure per
person in US$ and Gross Domestic Product (GDP) in US$
Purchase Price Parity ($PPP) per capita. All available data
date back to 1995, with the latest reported date being in
2014, enabling a review spanning nearly two decades so as to
adequately demonstrate trends. The data set covers countries
which, although within the Mediterranean region, stand at
different stages of economic evolution and financial system
progress, thereby providing a more representative sample owing
to their inherent diversity in financial standing. The use of charts
helps in providing clarity in the comparison of these countries
and across time.
RESULTS
National expenditure on healthcare has trended upwards for the
last quarter of the twentieth century, noting spiked investment
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in the industry from both the private and public sectors (15). An
increase in insurance companies is an indicator of this renewed
interest in the healthcare sector (16).
Figure 1 shows total per capita health expenditure (in
constant 2011 US$, adjusted for PPP) across all European
Union countries in 2014, subdivided according to funding source
FIGURE 1 | Public and private funding of the healthcare systems in the EU, in PPP$ per Capita [Source: (14)].
FIGURE 2 | Total health expenditure, as a% of GDP, 1995-2014 [Source: (14)].
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(i.e., private vs. public). As seen from the diagram, all of the
Mediterranean countries are below the EU average when it comes
to per capita health expenditure, with Italy being the closest and
Cyrus being the furthest. Mediterranean countries also spend
a lower proportion of their GDP on healthcare relative to the
EU average, as seen in Figure 2. Interestingly, all six countries
under review report a higher than average level of per capita
private health expenditures relative to the rest of the EU, both
in absolute terms and as a percentage of THE. Conversely, the
Mediterranean countries lag behind when it comes to public
health expenditures per capita, which implies that government
spending on health services in these countries is lower than
the EU average and is in turn being complemented by private
care spending. In line with this observation, the Mediterranean
countries under consideration also have higher-than-average
out-of-pocket (OOP) health expenditures relative to the rest
of the EU, as seen in Table 1, with Malta leading the way at
$709.02 per capita, some $200 more than the EU average of
$502.01. This is particularly important since OOPs may impose
a significant financial burden on citizens of a country, given that
such payments are not reimbursed by either the government or
TABLE 1 | 2014 out of pocket health expenditure per Capita, US$ [Source: (14)].
Country Out of pocket (OOP) health expenditure per capita
(US$, 2014)
Cyprus $659.83
Greece $609.57
Italy $690.11
Malta $709.02
Portugal $564.22
Spain $638.28
European Union $502.01
the private sector (17). Whether any of these factors have had
a significant impact on the quality of healthcare provision, or
indeed the availability of adequate health-related infrastructure,
remains to be seen and requires further analysis.
It is interesting to note the relationship between public
health spending and OOPs among European countries. As seen
in Figure 3 below, there seems to be a positive correlation
between the two variables, thus indicating that OOPs are
often complementary to public health spending, rather than
a substitute, at least within the EU. The fact that this trend
is reversed among our group of Mediterranean countries is
particularly intriguing, since lower-than-average public health
spending in these countries is being accompanied by higher-
than-average OOPs, thus shifting the burden of healthcare
provision from the state to the private individual.
We now turn to a more in-depth analysis of the economic
indicators of the countries under consideration. In Malta, THE
as a percentage of GDP increased from 5.7 to 9.7% between
1995 and 2014, the highest of any Mediterranean country.
Furthermore, Malta also experienced the highest growth in
THE per capita among the Mediterranean countries considered,
with an increase of almost 242% from US$898.48 in 1995 to
US$3071.63 in 2014 (Table 2). This is a significant development
by the country when considering the country’s size and
population. Inter alia, OOP (Out of Pocket Expenditure) per
capita has also increased from US$174 to US$709 over the
designated time frame, while the share of private expenditure
on health has remained broadly constant at 32–31%, albeit
with some variation over the years (with some variants
reaching 37% between 2008 and 2010). In fact, the share of
public health expenditure has also remained broadly constant
over this period, thereby indicating that Malta’s growth in
healthcare expenditure occurred across both private and public
sectors.
FIGURE 3 | Public health spending per capita and OOPs per capita in the EU [source: (14)].
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TABLE 2 | Select health expenditure indicators for mediterranean countries in
2014 [Source: (14)].
Total health
expenditure
per capita
Public
spending in
total
expenditure
Private
spending in
total health
expenditure
Proportion of total
government
expenditure on
health
Cyprus US$2,062.37 45.23% 54.77% 6.90%
Greece US$2,098.05 61.66% 38.34% 13.20%
Italy US$3,238.89 75.61% 24.39% 14.70%
Malta US$3,071.63 69.16% 30.84% 13.30%
Portugal US$2,689.94 64.82% 35.18% 13.40%
Spain US$2,965.82 70.88% 29.12% 15.40%
Portugal recorded a THE of 7.4% as a proportion of GDP in
1995, increasing to 9.5% by 2003 and staying relatively constant
over the next decade. Per capita healthcare expenditure grew
from US$1017.33 in 1995 to US$2689.94 in 2014, with minimal
growth recorded since 2008. The public-private decomposition
of healthcare has remained broadly constant over this period,
with a minor decline in the private sector’s share in healthcare
expenditure from 37 to 35%, although it is important to note
that the OOPS has increased from US$209 to US$563 within the
period 1995–2014.
In Spain, THE as a proportion of GDP increased from 7
to 9% over the period under review, although this has dipped
somewhat since 2010. The same can be said for per capita health
expenditure, which peaked at US$3038.79 in 2009 before settling
at US$2965.82 in 2014. The government’s share of THE in Spain
declined from 72% in 1995 to 70.9% in 2014, despite rising to
a high of 75.7% in 2009, with the private sector mirroring these
developments. This in part reflects the onset of the 2008-09 global
economic crisis which had a significant impact in Spain both
in terms of economic growth as well as government finances,
with austerity measures implemented in order to rein in public
spending and soaring debts.
Cyprus has the lowest level of healthcare expenditure in the
Mediterranean, both as a proportion of GDP, as well as in per
capita terms. Over the period under review, Cyprus recorded a
THE of 4.7% of the GDP in 1995, which increased to 7.4% by
2014. Likewise, per capita expenditure rose from US$731.35 in
1995 to US$2062.37 in 2014, albeit following three consecutive
years of decline. The government’s share in THE has grown
significantly over the period 1995 to 2014, from 35.8% to 45.2%,
while the share of private expenditure has fallen from 64.2 to
54.7%. Nonetheless, Cyprus continues to be the country with
the highest proportion of private health expenditure both in the
Mediterranean and indeed the rest of the EU, and is the only
country where the private sector accounts for the majority of
healthcare spending.
Italy’s THE reached 9.2% of GDP in 2014, up from 7.1%
in 1995, although recent years have been characterized by very
minimal growth and some minor declines, perhaps as a result of
the global financial crisis. In fact, although Italy has the highest
level of per capita healthcare expenditure in the Mediterranean
(US$3238.89 in 2014, compared to US$1559.33 in 1995), this has
been on a downward trajectory since 2011. The public sector’s
share in total healthcare expenditure has risen from 70.8% in
1995 to 75.6% in 2014, while the private sector’s share has fallen
from 29.2% in 1995 to 24.4% in 2014.
Greece’s THE trajectory has largely mirrored the country’s
economic fortunes, particularly in the aftermath of the global
financial crisis. In fact, as a percentage of GDP total healthcare
expenditure actually fell slightly over the period 1995 to 2014,
from 8.3 to 8.1%, with the decline mainly concentrated in the
2009-2014 period. Health expenditure per capita did increase
over the period under review, from US$1266.563 in 1995 to
US$2098.05 in 2014, the smallest increase in the Mediterranean,
mainly as a result of a steep decline from US$3012.66 in 2008,
coinciding with the economic crisis and subsequent austerity
program. It is interesting to note the sectoral share of healthcare
expenditure in Greece over this period, since in 1995 the private-
public shares were relatively similar at 48 and 52% respectively.
Since then however, the public sector’s share increased to 61.7%
in 2014, while the private sector’s share has fallen to 38.3%.
DISCUSSION
The results presented above point toward a number of key
similarities shared by the Mediterranean countries as regards
healthcare expenditure. More specifically, we observed that THE,
both in per capita terms and as a percentage of GDP, is lower in
these countries relative to the EU average, mainly as a result of
lower-than-average public health spending, albeit in most cases
this has increased over time. OOP health expenditure is also
higher in these countries relative to other European countries
(18), underlining the importance of private initiatives in the
provision of healthcare in the Mediterranean. This may be due
to the culture of people within these countries to require ‘person-
centered care’ which they might feel is not received through the
services offered through public medical care (1). Although, the
governments in these countries do provide free public health
services, the waiting time required to receive these services and
the personalized attention may not always meet the expectations
of people requiring these services, who would thereby opt for
private health care instead.
Furthermore, with the exception of Malta, THE across these
countries has stalled somewhat in recent years (both in per capita
terms and as a proportion of GDP), which can be linked to
the 2008-09 global macro-economic and financial crisis and the
impact that this had within these countries in terms of dampened
economic conditions, as well as austerity measures to control
public finances (18).
When analyzing whether these salient characteristics have had
any discernible impact on the actual quality and infrastructure
of healthcare in these six Mediterranean countries, we take note
of (vide Figure 4) the number of physicians working in each
country, together with the number of hospital beds (per 1,000
inhabitants), for the year 2014. It is clear that when looking
at the supply of physicians, only Cyprus is lagging behind the
EU average of 3.55 per 1,000 people, which may reflect the
fact that it has the lowest level of healthcare expenditure in the
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FIGURE 4 | No. of physicians and hospital beds (per 1,000 people) in 2014 [Source: (14)].
FIGURE 5 | OOPs per capita and the number of physicians per 1,000 inhabitants in the EU [Source: (14)].
Mediterranean. All other countries are above the EU average,
with Greece leading the way with 6.3 physicians per 1,000 people.
Thus it is clear that, for the vast majority of Mediterranean
countries, the relatively high proportion of private sector
financing coupled with lower-than-average healthcare spending
does not translate into lower physician numbers, since most
exceed the EU average. In fact, a simple scatter plot of the number
of physicians per 1,000 inhabitants against OOPs per capita
(Figure 5) shows that the two are generally positively-correlated
within the EU, implying that countries with higher OOPs also
have a higher proportion of physicians, perhaps reflecting the
prevalence of private healthcare providers.
Matters are however somewhat different when it comes to the
supply of hospital beds, since all six Mediterranean countries lag
behind the EU average of 519.01 beds per 1,000 people. Malta has
the highest number of hospital beds among this group, at 466.6
per 1,000 people, with Spain at the other end of the spectrumwith
296.6. An adequate supply of hospital beds is a crucial component
of any country’s healthcare infrastructure (19), andmay therefore
have an impact on the quality of service provided. Figure 6 below
shows the number of hospital beds plotted against OOPs per
capita in the EU. As seen from the diagram, the two variables
are negatively-correlated, which indicates that those countries
with high OOPs tend to have a smaller supply of hospital beds.
Although the direction of causation is somewhat open to debate,
it may well be the case that high OOPs are simply the result of
weak supply conditions as captured by the availability of hospital
beds, which necessitate higher private expenditures in order to
ensure quick service.
We then consider various cross-country indicators of
healthcare quality to assess the Mediterranean countries’ overall
performance. We start with the World Health Organization’s
ranking of the world’s health systems (20), which was issued
in 2000 as a definitive guide to the quality of healthcare across
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FIGURE 6 | OOPs per capita and the number of hospital beds per 1,000 inhabitants in the EU [Source: (14)].
its 191 member countries. All six Mediterranean countries
ranked in the top 25 countries; indeed, Italy (2nd), Malta (5th),
and Spain (7th) all ranked in the top ten, with only Cyprus
somewhat lagging behind in 24th, which is still above several
high income countries like Germany, Canada and the USA.
Clearly, any tangible conclusions drawn from this ranking must
be taken with some caution, both due to the controversial nature
of this ranking system (21), which has never been updated,
coupled with the dated nature of the ranking itself, which
does not take into account more recent events such as the
ramifications of the 2008-09 economic crisis (22). Nonetheless,
at face value this ranking appears to show that the quality of
healthcare systems within these six Mediterranean countries is in
excellent shape, generally outperforming those in other European
countries.
Another potential set of indicators is related to mortality
rates and life expectancy at birth, which are both used in the
computation of the United Nation’s Human Development Index
(23). Figure 6 plots the crude death rate in each country (per
1,000 inhabitants) and the life expectancy at birth. With regard
to the death rate, things are somewhat mixed; three countries,
namely Cyprus (6.8), Malta (7.7), and Spain (8.5) are all below
the EU average of 9.73 deaths per 1,000 people, while the other
three, namely Italy (9.8), Portugal (10.1), and Greece (10.4)
are all above. Cyprus is of particular interest, given that it
has both the lowest level of healthcare expenditure per capita
and the lowest number of physicians per 1,000 inhabitants,
and yet still has the lowest death rate, which may reflect other
generally-favorable health conditions within the country. When
it comes to life expectancy, all six Mediterranean countries are
above the EU average of 80.9 years, with Spain leading the
way at 83.3 years. Closely followed by Italy (83.2 years). Thus,
these indicators do not highlight any significant issues when it
comes to health outcomes in terms of deaths or life expectancy,
although this ignores the incidence of illnesses and quality of life
considerations.
The information observed above is adequate to draw a number
of conclusions. It is backed by some secondary materials.
As with the rest of the countries under consideration, Malta
has two healthcare systems (public and private), and practitioners
are allowed to participate in the private system, as well as the
public system. The public or government healthcare platform
is free to all Maltese and European citizens (24). However, the
private sector utilizes insurance policies to provide medical care
to the patients who opt for it (25). Foreigners in Malta are
encouraged to use the private healthcare system and are advised
to takemedical insurance for the same purpose (26). Financing in
the healthcare sector is therefore predominately sourced from the
public sector (24, 25). The quality of Malta’s healthcare services is
uniquely high and, as mentioned earlier, the country was ranked
fifth by WHO in 2000 (20).
Portugal’s healthcare system is driven by subsystems that
merge the objectives of both the private and public healthcare
systems (27). Some of these include mutual funds, private
health insurance, and social health insurances models for specific
professionals. The National Health Service (Serviço Nacional de
Saúde, or SNS) is managed by the Ministry of Health which is
also responsible for policy development (27). Changes in total
healthcare expenditures in recent years are attributable to various
developments, including government policies aimed at reducing
public expenditures, the influx of immigrants to Portugal (28),
as well as the 2005 primary healthcare reform which sought to
improve the overall efficiency and effectiveness of the healthcare
system by decentralizing the operation of State-run health centers
through the establishment of autonomous Family Health Units
(29).
In Spain, the publicly-funded Spanish Health Service (or SHS)
provides free medical treatment for all patients, who undertake a
consultation with a doctor who is recognized by or affiliated with
the Spanish State Health Service (30), with coverage reaching
99.1% of the Spanish population in 2003 (31). Otherwise, one
is required to pay as a private patient or use private insurance
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to cover the bill (32). The healthcare system is largely funded
by the government from social security and taxation receipts,
although as seen earlier the private sector accounts for roughly
a quarter of the overall industry (11, 32). Since 2002, the
operation of the SHS has been completely devolved to the
regional level, whereby each region is responsible both for the
allocation of funds across different healthcare uses as well as
the collection of revenues to fund the system. Despite these
reforms, a number of key challenges remain, including improved
integration and harmonization of healthcare across autonomous
states, public accountability and financial sustainability in light of
the economic crisis (33).
Cyprus has a dual healthcare system which, uniquely to the
rest of the European countries, is largely skewed toward the
private sector, although in recent years public health provision
has grown in importance. Cyprus is the only EU member state
without (near) universal public health coverage, with around 83%
of the population in 2014 covered by free healthcare (12). The
nature of the current healthcare system in Cyprus encourages
residents to take up private insurance since the public system is
largely inefficient, with problems related to coordination, waste
of resources and corruption in public hospitals (24, 34). In
2013 the Cypriot government, upon the recommendation of the
European Central Bank, the International Monetary Fund and
the European Commission, announced its intention to reform
the health service and establish a National Health Insurance
Scheme (NHIS), with the aim of ensuring universal coverage
(35). The new scheme was approved by the Cypriot Parliament
in June 2017, and full implementation is expected by 2020.
Under the new system, patients will be allowed a choice across
both private and public health service providers, and everyone
will have access to all medical interventions regardless of actual
contribution levels, with funding coming from government taxes,
worker contributions and employers.
Healthcare in Italy is largely operated by the public sector,
and has the second highest-ranked health service in the world
according to the World Health Organization (20). The national
health service, or the Sistema Sanitario Nazionale (SSN), has
been in operation since 1978 and provides universal healthcare
to all citizens. Similar to Spain, administrative, delivery and
financing responsibilities have largely been devolved to each of
the country’s 20 regions, a process which has been ongoing since
the early 1990s. Despite the impressive results obtained, the SSN
is currently facing a number of important challenges, notably
as a result of the economic crisis and associated pressures on
public finances (36). This has resulted in various cost-cutting
initiatives within the healthcare sector, such as a reduction in
health funding of e4.7 billion between 2012 and 2014, lower
expenditure caps on health equipment in 2010 as well as the
reintroduction of a e10 charge for all outpatients (37). Improved
harmonization and coordination across the disparate regional
healthcare providers also remains a priority, due to significant
heterogeneity in the quality of health services across autonomous
regions (38).
In Greece, public healthcare is provided by the National
Healthcare Service (ESY), built on the principle of universal
coverage (39). A public insurance company IKA (Idrima
Kinonikon Asfaliseon) is entrusted with administering the social
security system in Greece. Free medical services are provided on
the basis of a patient providing relevant applicable certification
to an IKA office where health services books are issued and
referrals to medical facilities housed under IKA are made. One
might be required to pay fees for secondary assessments such as
x-rays and certain medications which are not entirely free (39).
Therefore, the IKA scheme serves to assist the residents in taking
care of hospital expenses and not fully rendering free services.
Another issue of concern was the extensive growth of Greek
Pharmaceutical market largely driven by unsustainable policies
in dispensing and reimbursement of medicines (40).
Despite the high number of physicians per 1,000 people,
the Greek public health system has long been plagued
by inefficiencies in management and organization, requiring
significant reforms (41). The global economic crisis has
undoubtedly had the largest impact on Greece’s public healthcare
system in recent years (42, 43). In the wake of the crisis, total
spending on healthcare (in real terms) shrank by over a third
between 2009 and 2013, mainly as a result of government funding
cuts due to austerity measures aimed at controlling spiraling
public debt levels, including a e1.8 billion cut in pharmaceutical
expenditure between 2009 and 2013 (12). Furthermore, reforms
enacted in 2011 saw the creation of the new National Health
Services Organization (EOPYY) instead of IKA, which sought to
move away from the idea of universal coverage to entitlement
on the basis of insurance status. With unemployment rates
reaching unprecedented levels (over 27% in 2013), this lead
to several people losing their entitlement status, while many
self-employed ceased to renew their plans amidst worsening
economic conditions (44). The Greek government has sought
to tackle this problem directly by enacting a new policy in
2014, extending coverage to the uninsured for prescription drugs,
emergency services in government hospitals and certain non-
emergency care, with further extensions to coverage enacted
in 2016 for certain vulnerable groups like the registered
unemployed and refugees.
STUDY LIMITATIONS
The study incorporated information from different sources to
ensure that it maintained accurate information for the analysis
required. However, the time period considered, 1995-2014, is
an accurate long-run indicator. Additionally, one must also take
into account the unique factors that characterized both the last
quarter of the twentith century, including mass development
of industries, cities and economies (45), as well as the onset
of the global economic crisis in 2008-09, which may limit the
generalizability of these findings to other territories or time
periods.
It is also arguable that the reports filed by individual countries
through their various agencies might be fixed and, therefore,
unreliable (46). We sought to mitigate against such occurrences
through the use of data provided by international organizations
like the World Health Organization to ensure objectivity and
comparability throughout this study.
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CONCLUSION
With this study, we have sought to analyze healthcare provision
and expenditure across six Mediterranean countries (including
Portugal) forming part of the European Union. To this end,
we considered various indicators and statistics in order to
derive commonalities and differences across these countries. We
compared their overall trends to those observed across the rest of
the European Union. We then analyzed these findings in light of
other data related to the quality of healthcare and infrastructure
within these countries, before looking at recent developments
within each country and the main challenges faced.
The results show that on average, theMediterranean countries
spend less on total healthcare expenditure than the EU average,
both as a proportion of GDP as well as in per capita terms.
This is primarily driven by lower-than-average public funding of
healthcare, which must be considered in light of the economic
crisis which had a significant impact on the countries under
review, and reductions in public spending due to austerity
measures. On the flipside, the Mediterranean countries have a
higher presence of private health providers in total funding, while
OOP health expenditures are higher in these countries relative to
the average in the EU.
With regard to the overall health infrastructure in these
countries, we observed that although the supply of physicians is
largely in line with the rest of the EU, there is under-supply when
it comes to hospital beds, which may be symptomatic of lower
government funding and thus driving higher OOPs. Nonetheless,
all countries score highly when it comes to evaluating the
quality of the health services, both according to independent
international rankings like the WHO’s 2000 metric as well as
other indicators like mortality rates and life expectancy, which
all point toward favorable health outcomes in the Mediterranean.
Many of the countries analyzed in this paper have undertaken
significant healthcare reforms in recent years, with the aim of
improving efficiency and quality in healthcare provision and
thereby decreasing the high out-of-pocket healthcare spending.
The economic crisis has stifled these reforms to some extent,
since in many countries like Greece and Italy significant cuts to
public health expenditure were enacted in order to rein in rising
debt levels. Therefore, a major challenge faced by these countries
is to ensure maximum coverage for citizens, particularly the most
vulnerable members of society, all while faced with tightening
public health budgets. This further emphasizes the importance of
public sector reforms in terms of ensuring improved efficiency,
governance and management of public health administration.
Furthermore, increased decentralization and autonomy of public
health management at the regional level, which is a feature of
many countries in the Mediterranean and indeed across Europe,
brings new challenges like ensuring coordination across regions
and consistency of quality standards to avoid the creation of
regional disparities in healthcare provision, which in turn may
exacerbate existing disparities in economic and social outcomes.
Besides these financial and administrative challenges,
various socio-economic and cultural developments across the
Mediterranean may have important implications for healthcare
systems in these countries. One such development is increased
migratory flows from North African countries, which have
grown significantly over the last two decades and which place
further pressures on public healthcare and the need for universal
coverage (47). Another factor is the growing proportion of
over-60 citizens in the population of most developed countries,
including those in the Mediterranean (48), which will necessitate
increased investment in specialized care and infrastructure to
cater for these specific needs. Finally, the increased incidence
of cardiovascular diseases and diabetes, often associated
FIGURE 7 | Obesity rates (as % of population aged 18 or over) and circulatory disease death rates (as % of total deaths) in 2014 [Source: (49, 50)].
Frontiers in Public Health | www.frontiersin.org 9 May 2018 | Volume 6 | Article 145
Grima et al. High Out-of-Pocket Health Spending
with lifestyle factors and obesity, must also be tackled by
the relevant health authorities. Despite the apparent health
benefits of the much-lauded Mediterranean diet, the obesity
rate in Greece (17.3%), Malta (26%—the highest in the EU),
Portugal (16.6%) and Spain (16.7%), as shown in Figure 7,
is above the EU average of 15.9% of the adult population,
while the number of deaths caused by circulatory diseases is
also higher than the EU average of 37.1% of deaths in Greece
(39.7%) and Malta (37.7%). Thus, public health interventions
aimed at both preventing and treating the onset of obesity
and circulatory diseases is a leading priority for most of these
countries.
These findings further serve to emphasize the commonalities
observed in this group of EU Mediterranean countries, who
despite their diversity have clear similarities in terms of
socio-demographic developments, health outcomes, total health
expenditure patterns as well as the relative importance of private
healthcare providers in these countries. It is the intention of the
authors to invite future research, most likely using the health
care utilization model or related health sociology models to
explain the likelihood for people in these countries to go for OOP
expenditure.
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